|
PARVA expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.75799954990919E-10 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.08080005950728E-10 |
| Normal-vs-Stage2 |
2.15000000000076E-05 |
| Normal-vs-Stage3 |
7.178000E-04 |
| Normal-vs-Stage4 |
1.53669999947148E-07 |
| Stage1-vs-Stage2 |
9.286800E-01 |
| Stage1-vs-Stage3 |
2.048400E-01 |
| Stage1-vs-Stage4 |
2.490600E-01 |
| Stage2-vs-Stage3 |
3.708400E-01 |
| Stage2-vs-Stage4 |
2.300600E-01 |
| Stage3-vs-Stage4 |
5.273500E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.51759954497766E-10 |
| Normal-vs-AfricanAmerican |
1.68143000000009E-05 |
| Normal-vs-Asian |
1.292630E-01 |
| Caucasian-vs-AfricanAmerican |
4.258000E-01 |
| Caucasian-vs-Asian |
9.605400E-01 |
| AfricanAmerican-vs-Asian |
8.383600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.71918035363205E-12 |
| Normal-vs-Female |
2.738200E-02 |
| Male-vs-Female |
1.977530E-04 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
3.77580000043842E-07 |
| Normal-vs-Extreme_Weight |
3.83815201843163E-12 |
| Normal-vs-Obese |
4.07310000000161E-05 |
| Normal-vs-Extreme_Obese |
3.04980000143118E-08 |
| Normal_Weight-vs-Extreme_Weight |
1.821850E-01 |
| Normal_Weight-vs-Obese |
3.631600E-01 |
| Normal_Weight-vs-Extreme_Obese |
1.416420E-01 |
| Extreme_Weight-vs-Obese |
1.891810E-02 |
| Extreme_Weight-vs-Extreme_Obese |
3.037200E-01 |
| Obese-vs-Extreme_Obese |
8.722200E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
7.740400E-03 |
| Normal-vs-Age(41-60Yrs) |
3.30530000036688E-07 |
| Normal-vs-Age(61-80Yrs) |
4.44629888463055E-11 |
| Normal-vs-Age(81-100Yrs) |
2.61349999997051E-06 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.007200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.294400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.437800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.363900E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.629200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.279400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.71790359715374E-11 |
| Normal-VS-Type2 PRCC |
5.19620000360987E-08 |
| Normal-VS-KIRP CIMP |
2.21149999999337E-05 |
| Normal-VS-Unclassified PRCC |
1.815390E-01 |
| Type1 PRCC-VS-Type2 PRCC |
1.440970E-01 |
| Type1 PRCC-VS-KIRP CIMP |
6.279600E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
2.202400E-02 |
| Type2 PRCC-VS-KIRP CIMP |
2.552600E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
1.039790E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
1.294830E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
7.44459999979519E-07 |
| Normal-vs-N1 |
2.676700E-03 |
| Normal-vs-N2 |
1.496710E-03 |
| N0-vs-N1 |
2.870000E-01 |
| N0-vs-N2 |
8.367000E-01 |
| N1-vs-N2 |
4.231600E-01 |
|
|
